282 related articles for article (PubMed ID: 2861698)
1. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
Pittner H
Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
Jolly SR; Smith RD; Wolf PS; Russ TP
Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
[TBL] [Abstract][Full Text] [Related]
3. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological studies of celiprolol: I. Beta-blocking effect, intrinsic sympathomimetic activity, vasodilating and hypotensive effects].
Miura A; Kimura Y; Inoue K; Matsuzaki T; Ochi S; Hamada K; Hayashi S; Tamura M; Kano S; Kimura K
Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):191-200. PubMed ID: 1973398
[TBL] [Abstract][Full Text] [Related]
5. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
Pittner H
Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
Daemmgen JW; Engelhardt G; Pelzer H
Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
[TBL] [Abstract][Full Text] [Related]
7. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Hattori Y; Sakuma I; Nakao Y; Kanno M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonist.
Van Inwegen RG; Khandwala A; Gordon RJ; Sutherland CA; Wolf P; Pruss TP
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):127-44. PubMed ID: 2881517
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
11. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
Smith RD; Cobuzzi A; Wolf PS; Pruss TP
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
Beckmann R; Müller B; Schröder G; Stock G
Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
[TBL] [Abstract][Full Text] [Related]
13. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
14. [The specificity of action of penbutolol and propranolol and their optical isomers].
Kaiser J
Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
[TBL] [Abstract][Full Text] [Related]
15. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of the adrenoceptor activity of AY-28,925.
Rimele TJ; Heaslip RJ; Lee DK; Grimes D
J Pharmacol Exp Ther; 1986 Oct; 239(1):1-8. PubMed ID: 2876089
[TBL] [Abstract][Full Text] [Related]
17. Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.
Wolf PS; Pruss TP; Rand MJ; Smith RD; Mann WS; Romano DV
J Hypertens Suppl; 1985 Dec; 3(3):S195-7. PubMed ID: 2908816
[TBL] [Abstract][Full Text] [Related]
18. [Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)].
Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
Wien Klin Wochenschr; 1978 May; 90(10):350-4. PubMed ID: 26139
[TBL] [Abstract][Full Text] [Related]
19. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of celiprolol.
Louis WJ; Drummer OH; Tung LH
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
